LM

Lisa McIntyre

Fisher & Paykel Healthcare Corporation Limited | Non-Executive Director
Dr McIntyre background is in strategy, particularly in the areas of medical technology and healthcare, with many years as a partner at L.E.K. Consulting in the US and Australia, where she led the Asia Pacific Health practice. Dr. McIntyre was a Director of the Garvan Institute of Medical Research for 12 years and is a Senate Fellow of the University of Sydney. She is currently a Non-executive Director of Fisher and Paykel Healthcare Corporation Limited, HCF Group, HCF Life, HCF Foundation, and Studiosity Pty Ltd. She is member of the Risk Committee and Chair of the R&D and Innovation Committee from 1st January 2023.

Companies and Roles

Company
Title
Tenure
Since
FPH
Fisher & Paykel Healthcare Corporation Limited
  • Non-Executive Director
2yrs, 7mthOct 2021
NAN
Nanosonics Limited
  • Non-Executive Director
4yrs, 5mthDec 2019

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
NAN
Nanosonics Limited
30/06/23N/A21,351N/AN/A
FPH
Fisher & Paykel Healthcare Corporation Limited
31/03/239,980N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
NAN
Nanosonics Limited
07/09/22
Buy
5,000$3.999$19,994On-market trade
FPH
Fisher & Paykel Healthcare Corporation Limited
29/08/22
Buy
5,500$19.689$108,287As advised by the company
FPH
Fisher & Paykel Healthcare Corporation Limited
06/12/21
Buy
4,400$32.452$142,790As advised by the company
NAN
Nanosonics Limited
25/02/21
Buy
8,150$6.133$49,980On-market trade
NAN
Nanosonics Limited
02/09/20
Buy
8,201$6.088$49,930On-market trade